1. Home
  2. FPH vs AVIR Comparison

FPH vs AVIR Comparison

Compare FPH & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPH
  • AVIR
  • Stock Information
  • Founded
  • FPH 2009
  • AVIR 2012
  • Country
  • FPH United States
  • AVIR United States
  • Employees
  • FPH N/A
  • AVIR N/A
  • Industry
  • FPH Real Estate
  • AVIR Medicinal Chemicals and Botanical Products
  • Sector
  • FPH Finance
  • AVIR Health Care
  • Exchange
  • FPH Nasdaq
  • AVIR Nasdaq
  • Market Cap
  • FPH 338.2M
  • AVIR 273.7M
  • IPO Year
  • FPH 2017
  • AVIR 2020
  • Fundamental
  • Price
  • FPH $4.95
  • AVIR $2.97
  • Analyst Decision
  • FPH
  • AVIR Hold
  • Analyst Count
  • FPH 0
  • AVIR 1
  • Target Price
  • FPH N/A
  • AVIR $6.00
  • AVG Volume (30 Days)
  • FPH 155.4K
  • AVIR 381.8K
  • Earning Date
  • FPH 04-24-2025
  • AVIR 05-13-2025
  • Dividend Yield
  • FPH N/A
  • AVIR N/A
  • EPS Growth
  • FPH 25.45
  • AVIR N/A
  • EPS
  • FPH 0.96
  • AVIR N/A
  • Revenue
  • FPH $237,926,000.00
  • AVIR N/A
  • Revenue This Year
  • FPH N/A
  • AVIR N/A
  • Revenue Next Year
  • FPH N/A
  • AVIR N/A
  • P/E Ratio
  • FPH $5.16
  • AVIR N/A
  • Revenue Growth
  • FPH 12.37
  • AVIR N/A
  • 52 Week Low
  • FPH $2.83
  • AVIR $2.60
  • 52 Week High
  • FPH $6.71
  • AVIR $4.15
  • Technical
  • Relative Strength Index (RSI)
  • FPH 44.93
  • AVIR 51.96
  • Support Level
  • FPH $4.61
  • AVIR $2.77
  • Resistance Level
  • FPH $5.15
  • AVIR $2.98
  • Average True Range (ATR)
  • FPH 0.27
  • AVIR 0.21
  • MACD
  • FPH -0.01
  • AVIR 0.02
  • Stochastic Oscillator
  • FPH 41.16
  • AVIR 64.91

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Share on Social Networks: